Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents

The use of functional magnetic resonance imaging (fMRI) techniques for evaluation of pharmacologic stimuli has great potential for understanding neurotransmitter dynamics for a number of brain disorders, such as drug abuse, schizophrenia, epilepsy, or neurodegeneration. Unfortunately, blood oxygenation level‐dependent (BOLD) imaging at common fields strengths, such as 1.5 or 3 T, has very low sensitivity and contrast‐to‐noise ratios (CNRs). We demonstrate here the utility of using an intravascular superparamagnetic iron oxide contrast agent with a long plasma half‐life for evaluation of hemodynamic changes related to dopaminergic stimuli using amphetamine or the cocaine analog 2β‐carbomethoxy‐3β‐(4‐fluorophenyl)tropane (CFT). We refer to this technique as increased relaxation with iron oxide nanoparticles (IRON). Results obtained here show that even at field strengths as high as 4.7 T, one can obtain increases in CNR by factors of 2–3 over BOLD imaging that lead to greater than an order of magnitude increase in statistical power with greatly increased sensitivity to hemodynamic changes in brain regions difficult to observe using BOLD imaging. Furthermore, use of the intravascular contrast agent allows for a meaningful physiologic parameter to be measured (relative cerebral blood volume (rCBV)), compared to conventional BOLD imaging. J. Magn. Reson. Imaging 2001;14:517–524. © 2001 Wiley‐Liss, Inc.

[1]  B. Westerink,et al.  Brain microdialysis and its application for the study of animal behaviour , 1995, Behavioural Brain Research.

[2]  J C Gore,et al.  Physiological basis for BOLD MR signal changes due to neuronal stimulation: Separation of blood volume and magnetic susceptibility effects , 1998, Magnetic resonance in medicine.

[3]  R. Turner,et al.  Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R R Edelman,et al.  Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). , 1995, AJR. American journal of roentgenology.

[5]  M H Buonocore,et al.  Noise suppression digital filter for functional magnetic resonance imaging based on image reference data , 1997, Magnetic resonance in medicine.

[6]  J Keegan,et al.  Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography , 1999, Journal of magnetic resonance imaging : JMRI.

[7]  E. DeYoe,et al.  Reduction of physiological fluctuations in fMRI using digital filters , 1996, Magnetic resonance in medicine.

[8]  B. Rosen,et al.  Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation , 1998, Magnetic resonance in medicine.

[9]  Christer Carlsson,et al.  Influence of Amphetamine Sulphate on Cerebral Blood Flow and Metabolism , 1975 .

[10]  Donald S. Williams,et al.  Perfusion imaging , 1992, Magnetic resonance in medicine.

[11]  B. Rosen,et al.  MR Contrast Due to Microscopically Heterogeneous Magnetic Susceptibility: Numerical Simulations and Applications to Cerebral Physiology , 1991, Magnetic resonance in medicine.

[12]  J. Haxby,et al.  Localization of Cardiac-Induced Signal Change in fMRI , 1999, NeuroImage.

[13]  S. Hyman,et al.  Acute Effects of Cocaine on Human Brain Activity and Emotion , 1997, Neuron.

[14]  A. D. de Crespigny,et al.  High-Resolution Functional Magnetic Resonance Imaging of the Rat Brain: Mapping Changes in Cerebral Blood Volume Using Iron Oxide Contrast Media , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  B R Rosen,et al.  Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment. , 1999, Neuroreport.

[16]  J. R. Baker,et al.  The intravascular contribution to fmri signal change: monte carlo modeling and diffusion‐weighted studies in vivo , 1995, Magnetic resonance in medicine.

[17]  B R Rosen,et al.  Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data , 1997, Magnetic resonance in medicine.

[18]  B. Rosen,et al.  Regional sensitivity and coupling of BOLD and CBV changes during stimulation of rat brain , 2001, Magnetic resonance in medicine.

[19]  T. L. Davis,et al.  Calibrated functional MRI: mapping the dynamics of oxidative metabolism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B R Rosen,et al.  Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET , 2000, Synapse.

[21]  R. Wightman,et al.  Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.

[22]  R. Weisskoff,et al.  Effect of temporal autocorrelation due to physiological noise and stimulus paradigm on voxel‐level false‐positive rates in fMRI , 1998, Human brain mapping.

[23]  R Weissleder,et al.  Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.

[24]  R Weissleder,et al.  Continuous assessment of perfusion by tagging including volume and water extraction (CAPTIVE): A steady‐state contrast agent technique for measuring blood flow, relative blood volume fraction, and the water extraction fraction , 1998, Magnetic resonance in medicine.

[25]  G. Radda,et al.  Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. , 1982, Biochimica et biophysica acta.

[26]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[27]  M. Fabry,et al.  Effect of magnetic susceptibility on nuclear magnetic resonance signals arising from red cells: a warning. , 1983, Biochemistry.

[28]  B. Rosen,et al.  MRI measurement of the temporal evolution of relative CMRO2 during rat forepaw stimulation , 1999, Magnetic resonance in medicine.

[29]  B. Rosen,et al.  Functional mapping of the human visual cortex by magnetic resonance imaging. , 1991, Science.

[30]  Karl J. Friston,et al.  Analysis of fMRI Time-Series Revisited , 1995, NeuroImage.

[31]  Donald S. Williams,et al.  Multi‐Slice MRI of Rat Brain Perfusion During Amphetamine Stimulation Using Arterial Spin Labeling , 1995, Magnetic resonance in medicine.

[32]  J. Mandeville,et al.  Vascular filters of functional MRI: Spatial localization using BOLD and CBV contrast , 1999, Magnetic resonance in medicine.

[33]  B. Rosen,et al.  Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects , 1988, Magnetic resonance in medicine.

[34]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[35]  Ravi S. Menon,et al.  Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. , 1992, Proceedings of the National Academy of Sciences of the United States of America.